X-Ray Equipped with Artificial Intelligence: Changing the COVID-19 Diagnostic Paradigm during the Pandemic

Mobile Apps for COVID-19 Detection and Diagnosis for Future Pandemic Control: Multidimensional Systematic Review

BACKGROUND

In the modern world, mobile apps are essential for human advancement, and pandemic control is no exception. The use of mobile apps and technology for the detection and diagnosis of COVID-19 has been the subject of numerous investigations, although no thorough analysis of COVID-19 pandemic prevention has been conducted using mobile apps, creating a gap.

OBJECTIVE

With the intention of helping software companies and clinical researchers, this study provides comprehensive information regarding the different fields in which mobile apps were used to diagnose COVID-19 during the pandemic.

METHODS

In this systematic review, 535 studies were found after searching 5 major research databases (ScienceDirect, Scopus, PubMed, Web of Science, and IEEE). Of these, only 42 (7.9%) studies concerned with diagnosing and detecting COVID-19 were chosen after applying inclusion and exclusion criteria using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) protocol.

RESULTS

Mobile apps were categorized into 6 areas based on the content of these 42 studies: contact tracing, data gathering, data visualization, artificial intelligence (AI)-based diagnosis, rule- and guideline-based diagnosis, and data transformation. Patients with COVID-19 were identified via mobile apps using a variety of clinical, geographic, demographic, radiological, serological, and laboratory data. Most studies concentrated on using AI methods to identify people who might have COVID-19. Additionally, symptoms, cough sounds, and radiological images were used more frequently compared to other data types. Deep learning techniques, such as convolutional neural networks, performed comparatively better in the processing of health care data than other types of AI techniques, which improved the diagnosis of COVID-19.

CONCLUSIONS

Mobile apps could soon play a significant role as a powerful tool for data collection, epidemic health data analysis, and the early identification of suspected cases. These technologies can work with the internet of things, cloud storage, 5th-generation technology, and cloud computing. Processing pipelines can be moved to mobile device processing cores using new deep learning methods, such as lightweight neural networks. In the event of future pandemics, mobile apps will play a critical role in rapid diagnosis using various image data and clinical symptoms. Consequently, the rapid diagnosis of these diseases can improve the management of their effects and obtain excellent results in treating patients.

Non-invasive fractional flow reserve estimation using deep learning on intermediate left anterior descending coronary artery lesion angiography images

This study aimed to design an end-to-end deep learning model for estimating the value of fractional flow reserve (FFR) using angiography images to classify left anterior descending (LAD) branch angiography images with average stenosis between 50 and 70% into two categories: FFR > 80 and FFR ≤ 80. In this study 3625 images were extracted from 41 patients' angiography films. Nine pre-trained convolutional neural networks (CNN), including DenseNet121, InceptionResNetV2, VGG16, VGG19, ResNet50V2, Xception, MobileNetV3Large, DenseNet201, and DenseNet169, were used to extract the features of images. DenseNet169 indicated higher performance compared to other networks. AUC, Accuracy, Sensitivity, Specificity, Precision, and F1-score of the proposed DenseNet169 network were 0.81, 0.81, 0.86, 0.75, 0.82, and 0.84, respectively. The deep learning-based method proposed in this study can non-invasively and consistently estimate FFR from angiographic images, offering significant clinical potential for diagnosing and treating coronary artery disease by combining anatomical and physiological parameters.

Artificial intelligence applied to analyzes during the pandemic: COVID-19 beds occupancy in the state of Rio Grande do Norte, Brazil

The COVID-19 pandemic is already considered one of the biggest global health crises. In Rio Grande do Norte, a Brazilian state, the RegulaRN platform was the health information system used to regulate beds for patients with COVID-19. This article explored machine learning and deep learning techniques with RegulaRN data in order to identify the best models and parameters to predict the outcome of a hospitalized patient. A total of 25,366 bed regulations for COVID-19 patients were analyzed. The data analyzed comes from the RegulaRN Platform database from April 2020 to August 2022. From these data, the nine most pertinent characteristics were selected from the twenty available, and blank or inconclusive data were excluded. This was followed by the following steps: data pre-processing, database balancing, training, and test. The results showed better performance in terms of accuracy (84.01%), precision (79.57%), and F1-score (81.00%) for the Multilayer Perceptron model with Stochastic Gradient Descent optimizer. The best results for recall (84.67%), specificity (84.67%), and ROC-AUC (91.6%) were achieved by Root Mean Squared Propagation. This study compared different computational methods of machine and deep learning whose objective was to classify bed regulation data for patients with COVID-19 from the RegulaRN Platform. The results have made it possible to identify the best model to help health professionals during the process of regulating beds for patients with COVID-19. The scientific findings of this article demonstrate that the computational methods used applied through a digital health solution, can assist in the decision-making of medical regulators and government institutions in situations of public health crisis.

Challenging ChatGPT 3.5 in Senology-An Assessment of Concordance with Breast Cancer Tumor Board Decision Making

With the recent diffusion of access to publicly available large language models (LLMs), common interest in generative artificial-intelligence-based applications for medical purposes has skyrocketed. The increased use of these models by tech-savvy patients for personal health issues calls for a scientific evaluation of whether LLMs provide a satisfactory level of accuracy for treatment decisions. This observational study compares the concordance of treatment recommendations from the popular LLM ChatGPT 3.5 with those of a multidisciplinary tumor board for breast cancer (MTB). The study design builds on previous findings by combining an extended input model with patient profiles reflecting patho- and immunomorphological diversity of primary breast cancer, including primary metastasis and precancerous tumor stages. Overall concordance between the LLM and MTB is reached for half of the patient profiles, including precancerous lesions. In the assessment of invasive breast cancer profiles, the concordance amounts to 58.8%. Nevertheless, as the LLM makes considerably fraudulent decisions at times, we do not identify the current development status of publicly available LLMs to be adequate as a support tool for tumor boards. Gynecological oncologists should familiarize themselves with the capabilities of LLMs in order to understand and utilize their potential while keeping in mind potential risks and limitations.

COVID-19 vaccine registry for pregnant women: policy to control complications of vaccination in pregnant women in 2021-2022

BACKGROUND

Data management related to COVID-19 vaccination in pregnant women is vital to improve the treatment process and to establish preventive programs. Implementing a registry to manage data is an essential part of this process. This study aims to design a national model of the COVID-19 vaccination registry for pregnant women in Iran.

METHODS

The present study is an applied descriptive study conducted in 2021 and 2022 in two stages. In the first stage, the coordinates of the National Registry of COVID-19 vaccination of pregnant women from related references and articles, as well as the comparative study of the National Registry of COVID-19 vaccination of pregnant women in the United States, Canada, and the United Kingdom was done. In the second stage, the preliminary model was designed. The model was validated using the Delphi technique and questionnaire tools and analyzing the data.

RESULTS

The presented national COVID-19 vaccination registry model of pregnant women's main components consist of objectives, data sources, structure, minimum data set, standards, and registry processes, all of which received 100% expert consensus.

CONCLUSION

The vaccination registry of pregnant women has a major role in managing COVID-19 vaccination data of pregnant women and can be one of the Ministry of Health and Medical Education priorities.

COV-MobNets: a mobile networks ensemble model for diagnosis of COVID-19 based on chest X-ray images

BACKGROUND

The medical profession is facing an excessive workload, which has led to the development of various Computer-Aided Diagnosis (CAD) systems as well as Mobile-Aid Diagnosis (MAD) systems. These technologies enhance the speed and accuracy of diagnoses, particularly in areas with limited resources or remote regions during the pandemic. The primary purpose of this research is to predict and diagnose COVID-19 infection from chest X-ray images by developing a mobile-friendly deep learning framework, which has the potential for deployment in portable devices such as mobile or tablet, especially in situations where the workload of radiology specialists may be high. Moreover, this could improve the accuracy and transparency of population screening to assist radiologists during the pandemic.

METHODS

In this study, the Mobile Networks ensemble model called COV-MobNets is proposed to classify positive COVID-19 X-ray images from negative ones and can have an assistant role in diagnosing COVID-19. The proposed model is an ensemble model, combining two lightweight and mobile-friendly models: MobileViT based on transformer structure and MobileNetV3 based on Convolutional Neural Network. Hence, COV-MobNets can extract the features of chest X-ray images in two different methods to achieve better and more accurate results. In addition, data augmentation techniques were applied to the dataset to avoid overfitting during the training process. The COVIDx-CXR-3 benchmark dataset was used for training and evaluation.

RESULTS

The classification accuracy of the improved MobileViT and MobileNetV3 models on the test set has reached 92.5% and 97%, respectively, while the accuracy of the proposed model (COV-MobNets) has reached 97.75%. The sensitivity and specificity of the proposed model have also reached 98.5% and 97%, respectively. Experimental comparison proves the result is more accurate and balanced than other methods.

CONCLUSION

The proposed method can distinguish between positive and negative COVID-19 cases more accurately and quickly. The proposed method proves that utilizing two automatic feature extractors with different structures as an overall framework of COVID-19 diagnosis can lead to improved performance, enhanced accuracy, and better generalization to new or unseen data. As a result, the proposed framework in this study can be used as an effective method for computer-aided diagnosis and mobile-aided diagnosis of COVID-19. The code is available publicly for open access at https://github.com/MAmirEshraghi/COV-MobNets .

Harnessing Machine Learning in Early COVID-19 Detection and Prognosis: A Comprehensive Systematic Review

During the early phase of the COVID-19 pandemic, reverse transcriptase-polymerase chain reaction (RT-PCR) testing faced limitations, prompting the exploration of machine learning (ML) alternatives for diagnosis and prognosis. Providing a comprehensive appraisal of such decision support systems and their use in COVID-19 management can aid the medical community in making informed decisions during the risk assessment of their patients, especially in low-resource settings. Therefore, the objective of this study was to systematically review the studies that predicted the diagnosis of COVID-19 or the severity of the disease using ML. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), we conducted a literature search of MEDLINE (OVID), Scopus, EMBASE, and IEEE Xplore from January 1 to June 31, 2020. The outcomes were COVID-19 diagnosis or prognostic measures such as death, need for mechanical ventilation, admission, and acute respiratory distress syndrome. We included peer-reviewed observational studies, clinical trials, research letters, case series, and reports. We extracted data about the study's country, setting, sample size, data source, dataset, diagnostic or prognostic outcomes, prediction measures, type of ML model, and measures of diagnostic accuracy. Bias was assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO), with the number CRD42020197109. The final records included for data extraction were 66. Forty-three (64%) studies used secondary data. The majority of studies were from Chinese authors (30%). Most of the literature (79%) relied on chest imaging for prediction, while the remainder used various laboratory indicators, including hematological, biochemical, and immunological markers. Thirteen studies explored predicting COVID-19 severity, while the rest predicted diagnosis. Seventy percent of the articles used deep learning models, while 30% used traditional ML algorithms. Most studies reported high sensitivity, specificity, and accuracy for the ML models (exceeding 90%). The overall concern about the risk of bias was "unclear" in 56% of the studies. This was mainly due to concerns about selection bias. ML may help identify COVID-19 patients in the early phase of the pandemic, particularly in the context of chest imaging. Although these studies reflect that these ML models exhibit high accuracy, the novelty of these models and the biases in dataset selection make using them as a replacement for the clinicians' cognitive decision-making questionable. Continued research is needed to enhance the robustness and reliability of ML systems in COVID-19 diagnosis and prognosis.

AMTLDC: a new adversarial multi-source transfer learning framework to diagnosis of COVID-19

In recent years, deep learning techniques have been widely used to diagnose diseases. However, in some tasks, such as the diagnosis of COVID-19 disease, due to insufficient data, the model is not properly trained and as a result, the generalizability of the model decreases. For example, if the model is trained on a CT scan dataset and tested on another CT scan dataset, it predicts near-random results. To address this, data from several different sources can be combined using transfer learning, taking into account the intrinsic and natural differences in existing datasets obtained with different medical imaging tools and approaches. In this paper, to improve the transfer learning technique and better generalizability between multiple data sources, we propose a multi-source adversarial transfer learning model, namely AMTLDC. In AMTLDC, representations are learned that are similar among the sources. In other words, extracted representations are general and not dependent on the particular dataset domain. We apply the AMTLDC to predict Covid-19 from medical images using a convolutional neural network. We show that accuracy can be improved using the AMTLDC framework, and surpass the results of current successful transfer learning approaches. In particular, we show that the AMTLDC works well when using different dataset domains, or when there is insufficient data.

Efficient Model for Coronary Artery Disease Diagnosis: A Comparative Study of Several Machine Learning Algorithms

Background

In today's industrialized world, coronary artery disease (CAD) is one of the leading causes of death, and early detection and timely intervention can prevent many of its complications and eliminate or reduce the resulting mortality. Machine learning (ML) methods as one of the cutting-edge technologies can be used as a suitable solution in diagnosing this disease.

Methods

In this study, different ML algorithms' performances were compared for their effectiveness in developing a model for early CAD diagnosis based on clinical examination features. This applied descriptive study was conducted on 303 records and overall 26 features, of which 26 were selected as the target features with the advice of several clinical experts. In order to provide a diagnostic model for CAD, we ran most of the most critical classification algorithms, including Multilayer Perceptron (MLP), Support Vector Machine (SVM), Logistic Regression (LR), J48, Random Forest (RF), K-Nearest Neighborhood (KNN), and Naive Bayes (NB). Seven different classification algorithms with 26 predictive features were tested to cover all feature space and reduce model error, and the most efficient algorithms were identified by comparison of the results.

Results

Based on the compared performance metrics, SVM (AUC = 0.88, F-measure = 0.88, ROC = 0.85), and RF (AUC = 0.87, F-measure = 0.87, ROC = 0.91) were the most effective ML algorithms. Among the algorithms, the KNN algorithm had the lowest efficiency (AUC = 0.81, F-measure = 0.81, ROC = 0.77). In the diagnosis of coronary artery disease, machine learning algorithms have played an important role. Proposed ML models can provide practical, cost-effective, and valuable support to doctors in making decisions according to a good prediction. Discussion. It can become the basis for developing clinical decision support systems. SVM and RF algorithms had the highest efficiency and could diagnose CAD based on patient examination data. It is suggested that further studies be performed using these algorithms to diagnose coronary artery disease to obtain more accurate results.

Efficient Framework for Detection of COVID-19 Omicron and Delta Variants Based on Two Intelligent Phases of CNN Models

Introduction

While the COVID-19 pandemic was waning in most parts of the world, a new wave of COVID-19 Omicron and Delta variants in Central Asia and the Middle East caused a devastating crisis and collapse of health-care systems. As the diagnostic methods for this COVID-19 variant became more complex, health-care centers faced a dramatic increase in patients. Thus, the need for less expensive and faster diagnostic methods led researchers and specialists to work on improving diagnostic testing.

Method

Inspired by the COVID-19 diagnosis methods, the latest and most efficient deep learning algorithms in the field of extracting X-ray and CT scan image features were used to identify COVID-19 in the early stages of the disease.

Results

We presented a general framework consisting of two models which are developed by convolutional neural network (CNN) using the concept of transfer learning and parameter optimization. The proposed phase of the framework was evaluated on the test dataset and yielded remarkable results and achieved a detection sensitivity, specificity, and accuracy of 0.99, 0.986, and 0.988, for the first phase and 0.997, 0.9976, and 0.997 for the second phase, respectively. In all cases, the whole framework was able to successfully classify COVID-19 and non-COVID-19 cases from CT scans and X-ray images.

Conclusion

Since the proposed framework was based on two deep learning models that used two radiology modalities, it was able to significantly assist radiologists in detecting COVID-19 in the early stages. The use of models with this feature can be considered as a powerful and reliable tool, compared to the previous models used in the past pandemics.

ADA-COVID: Adversarial Deep Domain Adaptation-Based Diagnosis of COVID-19 from Lung CT Scans Using Triplet Embeddings

Rapid diagnosis of COVID-19 with high reliability is essential in the early stages. To this end, recent research often uses medical imaging combined with machine vision methods to diagnose COVID-19. However, the scarcity of medical images and the inherent differences in existing datasets that arise from different medical imaging tools, methods, and specialists may affect the generalization of machine learning-based methods. Also, most of these methods are trained and tested on the same dataset, reducing the generalizability and causing low reliability of the obtained model in real-world applications. This paper introduces an adversarial deep domain adaptation-based approach for diagnosing COVID-19 from lung CT scan images, termed ADA-COVID. Domain adaptation-based training process receives multiple datasets with different input domains to generate domain-invariant representations for medical images. Also, due to the excessive structural similarity of medical images compared to other image data in machine vision tasks, we use the triplet loss function to generate similar representations for samples of the same class (infected cases). The performance of ADA-COVID is evaluated and compared with other state-of-the-art COVID-19 diagnosis algorithms. The obtained results indicate that ADA-COVID achieves classification improvements of at least 3%, 20%, 20%, and 11% in accuracy, precision, recall, and F1 score, respectively, compared to the best results of competitors, even without directly training on the same data. The implementation source code of the ADA-COVID is publicly available at https://github.com/MehradAria/ADA-COVID.

Application of artificial intelligence in diagnosing COVID-19 disease symptoms on chest X-rays: A systematic review

This systematic review focuses on using artificial intelligence (AI) to detect COVID-19 infection with the help of X-ray images. Methodology: In January 2022, the authors searched PubMed, Embase and Scopus using specific medical subject headings terms and filters. All articles were independently reviewed by two reviewers. All conflicts resulting from a misunderstanding were resolved by a third independent researcher. After assessing abstracts and article usefulness, eliminating repetitions and applying inclusion and exclusion criteria, six studies were found to be qualified for this study. Results: The findings from individual studies differed due to the various approaches of the authors. Sensitivity was 72.59%-100%, specificity was 79%-99.9%, precision was 74.74%-98.7%, accuracy was 76.18%-99.81%, and the area under the curve was 95.24%-97.7%. Conclusion: AI computational models used to assess chest X-rays in the process of diagnosing COVID-19 should achieve sufficiently high sensitivity and specificity. Their results and performance should be repeatable to make them dependable for clinicians. Moreover, these additional diagnostic tools should be more affordable and faster than the currently available procedures. The performance and calculations of AI-based systems should take clinical data into account.